News
Stryker Declares a $0.15 Per Share Quarterly Dividend
June 21, 2010 10:36 am | by Bio-Medicine.Org | CommentsKALAMAZOO, Mich. , June 21 /- Stryker Corporation (NYSE: SYK ) announced today that its Board of Directors has declared a quarterly dividend of $0.15 per share payable on July 30, 2010 to shareholders of record at the close of business on June 30, 2010 . Stryker is one of...
Former Medtronic executive gets top spot at Colorado spine firm
June 21, 2010 10:36 am | by Mass Device | CommentsMedtronic Inc.'s former chief operating officer Michael DeMane joins spinal surgery device company Lanx Inc. as chairman and CEO. By Thomas Lee Michael DeMane joined Lanx Inc. as chairman and CEO. The former chief operating officer at Medtronic Inc. (NYSE:MDT) was once...
HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference
June 21, 2010 10:35 am | by Bio-Medicine.Org | CommentsMINNEAPOLIS , June 21 /- HeartSine Technologies Ltd. recently joined 29 other companies on the 2010 Index 30, an annually compiled list of the most exciting companies with operations in the U.S. and Ireland . Other companies on this year's Index 30 list, compiled by The Irish Echo , the...
Vigil Health Q4 loss balloons as revenue drops
June 21, 2010 9:45 am | by The Associated Press | CommentsVigil Health Solutions Inc. saw its fourth-quarter and year-end losses balloon, hit by a drop in revenues for both periods.The company (TSXV:VGN), which provides emergency call and nurse call systems for seniors, said Monday its loss for the quarter ended March 31 increased to $235,782 from a...
Public Hearing: Development of Articles for Rare Diseases, June 29-30, 2010
June 21, 2010 9:35 am | by U.S. Food & Drug Administration | CommentsThis public hearing is intended to gain from health care providers, academia, industry, patients, and other interested persons their perspectives on various aspects of the development of medical products for the diagnosis, treatment, or management of...
How to become a salesperson of influence
June 21, 2010 9:35 am | by Mass Device | CommentsTen tips to help medical device salespeople become influential advisors to their hospital and physician customers. The other day I spoke to a sales trainer, who was a reference for a candidate. He talked about the difference between being a "pleaser" and an "adviser" to customers. The...
MedGadget's MedTech Monday: Custom-fit degradable cranial implant
June 21, 2010 8:35 am | by Mass Device | CommentsA custom-fit degradable implant for filling bone defects after craniofacial surgery; a study shows Bard's LifeStent as superior to stentless angioplasty; Micrus' DeltaPAQ and DeltaPlush microcoils cleared in Japan; and CorMatrix's cardiac tissue repair wins CE Mark. ...
EarlySense wins FDA clearance for patient monitoring system
June 21, 2010 8:35 am | by Mass Device | CommentsIsraeli-based medical device company EarlySense Ltd. receives U.S. Food & Drug Administration approval to sell its EverOn Touch patient monitoring system in the United States. By Mary Vanac Ramat Gan, Israel-based medical device company EarlySense Ltd., which recently...
Docs increasingly abandon Medicare
June 21, 2010 7:36 am | by Mass Device | CommentsMore and more physicians are cutting Medicare patients from their rosters after Congress fails to stay a 21 percent reimbursement rate cut. As Congress allowed a 21 percent reduction in reimbursement rates for doctors to come into effect, the number of physicians pulling out of...
Encouraging results from the largest clinical study ever conducted on treating depression with Omega-3
June 21, 2010 6:38 am | by EurekAlert | Comments(Centre hospitalier de l'Université de Montréal) The use of Omega-3 supplements is effective among patients with major depression who do not have anxiety disorders, according to a study directed by Dr. Francois Lesperance of the Centre de recherche du Centre hospitalier at the...
FDA to expedite ev3's Pipeline
June 21, 2010 6:37 am | by Mass Device | CommentsThe Food & Drug Administration grants ev3 Inc. an expedited review of the pre-market approval application the company filed in May for its Pipeline cerebral aneurysm treatment. One of Covidien plc's (NYSE:COV) pending acquisitions won some good news from the Food & Drug...
Covidien registers for debt sale to cover $2.3 billion ev3 buyout
June 21, 2010 6:36 am | by Mass Device | CommentsCovidien plc registers for an offering of an undisclosed amount of debt, aimed at raising cash to help pay for its $2.3 billion buyout of ev3 Inc. Covidien plc (NYSE:COV) registered for a debt offering with the Securities & Exchange Commission, aiming to drum up some cash...
Sinapis Pharma Commences Phase I Trial
June 21, 2010 6:36 am | by Bio-Medicine.Org | CommentsJACKSONVILLE, Fla. , June 21 /- Sinapis Pharma, Inc. announces that its first patients were dosed in a Phase I clinical trial study on June 14, 2010 . This study, in human volunteers, is designed to evaluate the safety, pharmacokinetics, and absolute bioavailability of an intravenous...
Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
June 21, 2010 6:36 am | by Bio-Medicine.Org | CommentsDOHA, Qatar , June 21 /- One of the leading cancer centers in the Middle East has become among the first in the region to introduce fast and efficient RapidArc® radiotherapy treatments from Varian Medical Systems (NYSE: VAR). Al Amal Hospital in Doha, Qatar , has treated nine brain...
U.S. FDA Approves Improved Performance of Riverain Medical's OnGuard Chest X-ray Computer-Aided Detection Technology
June 21, 2010 6:34 am | by Bio-Medicine.Org | CommentsDAYTON, Ohio , June 21 /- Riverain Medical® announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard™ Chest X-ray Computer-Aided Detection (CAD) technology. OnGuard identifies solitary pulmonary nodules that may...
